BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33023996)

  • 1. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
    Tsai APY; Hur SA; Wong A; Safavi M; Assayag D; Johannson KA; Morisset J; Fell C; Fisher JH; Manganas H; Shapera S; Cox G; Gershon AS; Hambly N; Khalil N; To T; Wilcox PG; Halayko A; Kolb MR; Ryerson CJ
    Thorax; 2021 Jan; 76(1):37-43. PubMed ID: 33023996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.
    Chen T; Tsai APY; Hur SA; Wong AW; Sadatsafavi M; Fisher JH; Johannson KA; Assayag D; Morisset J; Shapera S; Khalil N; Fell CD; Manganas H; Cox G; To T; Gershon AS; Hambly N; Halayko AJ; Wilcox PG; Kolb M; Ryerson CJ
    Respir Res; 2021 Jul; 22(1):202. PubMed ID: 34238283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness.
    Lin DY; Cheok TS; Kaambwa B; Samson AJ; Morrison C; Chan T; Kroon HM; Jaarsma RL
    Health Qual Life Outcomes; 2023 May; 21(1):41. PubMed ID: 37165364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.
    Nolan CM; Longworth L; Lord J; Canavan JL; Jones SE; Kon SS; Man WD
    Thorax; 2016 Jun; 71(6):493-500. PubMed ID: 27030578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study.
    Kuan WC; Chee KH; Kasim S; Lim KK; Dujaili JA; Lee KK; Teoh SL
    J Med Econ; 2024; 27(1):607-617. PubMed ID: 38557412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.
    Szentes BL; Kreuter M; Bahmer T; Birring SS; Claussen M; Waelscher J; Leidl R; Schwarzkopf L
    Respir Res; 2018 May; 19(1):101. PubMed ID: 29801506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the validity and responsiveness of the EQ-5D-5L to the Oxford hip and knee scores and SF-12 in osteoarthritis patients 1 year following total joint replacement.
    Conner-Spady BL; Marshall DA; Bohm E; Dunbar MJ; Noseworthy TW
    Qual Life Res; 2018 May; 27(5):1311-1322. PubMed ID: 29423757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
    Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
    Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form.
    Lin FJ; Pickard AS; Krishnan JA; Joo MJ; Au DH; Carson SS; Gillespie S; Henderson AG; Lindenauer PK; McBurnie MA; Mularski RA; Naureckas ET; Vollmer WM; Lee TA;
    BMC Med Res Methodol; 2014 Jun; 14():78. PubMed ID: 24934150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
    Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
    Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis.
    Chuang LH; Cohen AT; Agnelli G; Gumbs PD; Bauersachs R; Kroep S; Gitt AK; Monreal M; Willich SN; van Hout B
    Qual Life Res; 2019 May; 28(5):1155-1177. PubMed ID: 30607785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation.
    Chen P; Lin KC; Liing RJ; Wu CY; Chen CL; Chang KC
    Qual Life Res; 2016 Jun; 25(6):1585-96. PubMed ID: 26714699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients.
    Siriwardana AN; Hoffman AT; Morton RL; Smyth B; Brown MA
    Value Health; 2024 Apr; 27(4):469-477. PubMed ID: 38307389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
    Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
    Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danish population health measured by the EQ-5D-5L.
    Jensen MB; Jensen CE; Gudex C; Pedersen KM; Sørensen SS; Ehlers LH
    Scand J Public Health; 2023 Mar; 51(2):241-249. PubMed ID: 34847818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice.
    Lam CLK; Tse ETY; Wong CKH; Lam JSM; Chen SS; Bedford LE; Cheung JPY; Or CK; Kind P
    Health Qual Life Outcomes; 2021 Dec; 19(1):266. PubMed ID: 34922564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
    Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
    Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.